Molecular biology of testicular germ cell tumors

Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, et al. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet. 2006;15:443–51. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet. 2005;77:1034–43. Kanetsky PA, Mitra N, Vardhanabhuti S, Li M, Vaughn DJ, Letrero R, et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet. 2009;41:811–5. Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, Huddart RA, et al. A genome-wide association study of testicular germ cell tumor. Nat Genet. 2009;41:807–10. Turnbull C, Rahman N. Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour. Int J Androl 2011;34(4 Pt 2):e86–96 (Discussion e96–7). Yan W, Samson M, Jegou B, Toppari J. Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. Mol Endocrinol. 2000;14:682–99. Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet. 2010;42(7):604–7. doi:10.1038/ng.607. Ruark E, Seal S, McDonald H, Zhang F, Elliot A, Lau K, et al. Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet. 2013;. doi:10.1038/ng.2635. Andreassen KE, Kristiansen W, Karlsson R, Aschim EL, Dahl O, Fosså SD et al. Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor. Hum Reprod. 2013;28(7):1995–2002. doi:10.1093/humrep/det127 (Epub 2 May 2013). Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA et al. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet. 2013;22(13):2748–53. doi:10.1093/hmg/ddt109 (Epub 5 March 2013). Kristiansen W, Karlsson R, Rounge TB, Whitington T, Andreassen BK, Magnusson PK, et al. Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor. Hum Mol Genet. 2015;24(14):4138–46. doi:10.1093/hmg/ddv129 (Epub 15 April 2015). Skakkebaek NE, Rajpert-De Meyts E, Jørgensen N, Carlsen E, Petersen PM, Giwercman A et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS 1998;106(1):3–11 (Discussion 12). Chaganti RS, Houldsworth J. The cytogenetic theory of the pathogenesis of human adult male germ cell tumors. APMIS 1998;106(1):80–3 (Discussion 83–4). Germá JR, García del Muro X, Martínez M. Marcadores en tumores germinales de testículo. Rev Cancer (Madrid). 1996;10:85–96. Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2004;22:53–4. Houlsworth J, Kordola JE, Bosl GJ, Chaganti RS. Biology and genetics of adult male germ cell tumors. J Clin Oncol. 2006;24:5512. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W, et al. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res. 2004;64(14):4736–43. Almstrup K, Hoei-Hansen CE, Nielsen JE, Wirkner U, Ansorge W, Skakkebaek NE, et al. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br J Cancer. 2005;92(10):1934–41. Gillis AJ, Stoop H, Biermann K, van Gurp RJ, Swartzman E, Cribbes S, et al. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. Int J Androl. 2011;34(4 Pt 2):e160–74. doi:10.1111/j.1365-2605.2011.01148.x (Epub 2 June 2011). Jørgensen A, Nielsen JE, Almstrup K, Toft BG, Petersen BL, Rajpert-De Meyts E. Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ. J Pathol. 2013;229(4):588–98. doi:10.1002/path.4154. (Epub 4 Feb 2013). Alagaratnam S, Harrison N, Bakken AC, Hoff AM, Jones M, Sveen A, et al. Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells. Stem Cells Dev. 2013;22(7):1136–46. doi:10.1089/scd.2012.0369 (Epub 4 Jan 2013). Forbes S, Clements J, Dawson E, Bamford S, Webb T, Dogan A, et al. COSMIC 2005. Br J Cancer. 2006;94(2):318–22. Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl. 2011;34(4 Pt 2):e234–51. doi:10.1111/j.1365-2605.2011.01157.x (Epub 12 May 2011). Ishii T, Kohu K, Yamada S, Ishidoya S, Kanto S, Fuji H, et al. Up-regulation of DNA-methyltransferase 3A expression is associated with hypomethylation of intron 25 in human testicular germ cell tumors. Tohoku J Exp Med. 2007;212(2):177–90. Lian J, Tian H, Liu L, Zhang XS, Li WQ, Deng YM, et al. Downregulation of micro RNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1. Cell Death Dis. 2010;4(1):e94. doi:10.1038/cddis.2010.70. Ferreira H, Heyn H, Garcia del Muro X, Vidal A, Larriba S, Muñoz C, et al. Epigenetic loss of the PIWI/piRNA machinery in human testicular tumorigenesis. Epigenetics. 2014;9(1):113–8. doi:10.4161/epi.27237 (Epub 18 Nov 2013). Díez-Torre A, Silván U, Díaz-Núñez M, Aréchaga J. The role of microenvironment in testicular germ cell tumors. Cancer Biol Ther. 2010;10(6):529–36. doi:10.4161/cbt.10.6.13227 (Epub 3 Sept 2010). Milia-Argeiti E, Huet E, Labropoulou VT, Mourah S, Fenichel P, Karamanos NK, et al. Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours. Int J Androl. 2012;35(6):835–44. doi:10.1111/j.1365-2605.2012.01289.x (Epub 19 June 2012). Nettersheim D, Westernströer B, Haas N, Leinhaas A, Brüstle O, Schlatt S, et al. Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells. Genes Chromosomes Cancer. 2012;51(7):717–26. doi:10.1002/gcc.21958 (Epub 5 April 2012). Bi XC, Liu JM, He HC, Ye YK, Han ZD, Dai QS, et al. Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas. Clin Transl Oncol. 2012;14:190–6. Rago V, Romeo F, Giordano F, Ferraro A, Andò S, Carpino A. Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia. Reprod Biol Endocrinol. 2009;3(7):56. doi:10.1186/1477-7827-7-56. Ferlin A, Ganz F, Pengo M, Selice R, Frigo AC, Foresta C. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes. Endocr Relat Cancer. 2010;17(1):17–25. doi:10.1677/ERC-09-0176. Chevalier N, Vega A, Bouskine A, Siddeek B, Michiels JF, Chevallier D et al. GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One 2012;7(4):e34672. doi:10.1371/journal.pone.0034672 (Epub 4 April 2012). Ajj H, Chesnel A, Pinel S, Plenat F, Flament S, Dumond H et al. An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism. PLoS One 2013;8(4):e61758. doi:10.1371/journal.pone.0061758. Noel EE, Yeste-Velasco M, Mao X, Perry J, Kudahetti SC, Li NF, et al. The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers. Am J Pathol. 2010;176(6):2607–15. doi:10.2353/ajpath.2010.090780 (Epub 15 April 2010). Juliachs M, Munoz C, Moutinho CA, Vidal A, Condom E, Esteller M, et al. The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors. Clin Cancer Res. 2014;20(3):658–67. doi:10.1158/1078-0432.CCR-13-1131 (Epub 25 November 2013). Gutekunst M, Oren M, Weilbacher A, Dengler MA, Markwardt C, Thomale J, et al. p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin. PLoS One. 2011;6(4):e19198. doi:10.1371/journal.pone.0019198. Ushida H, Chano T, Minami K, Kita H, Kawakami T, Okabe H, et al. Therapeutic potential of SOX2 inhibition for embryonal carcinoma. J Urol. 2012;187(5):1876–81. doi:10.1016/j.juro.2011.12.058 (Epub 16 March 2012). Bremmer F, Thelen P, Pottek T, Behnes CL, Radzun HJ, Schweyer S. Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis. Anticancer Res. 2012;32(1):341–9. Giannatempo P, Paolini B, Miceli R, Raggi D, Nicolai N, Farè E, et al. Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatment. J Urol. 2013. doi:10.1016/j.juro.2013.04.057 (Epub ahead of print). Hatakeyama S, Kyan A, Yamamoto H, Okamoto A, Sugiyama N, Suzuki Y, et al. Core 2N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. Int J Cancer. 2010;127(5):1052–9. doi:10.1002/ijc.25117. Mohamed GH, Gelfond JA, Nicolas MM, Brand TC, Sarvis JA, Leach RJ, et al. Genomic characterization of testis cancer: association of alterations with outcome of clinical stage 1 mixed germ cell nonseminomatous germ cell tumor of the testis. Urology. 2012;80(2):485.e1–5. doi:10.1016/j.urology.2012.02.026 (Epub 13 April 2012). Arai E, Nakagawa T, Wakai-Ushijima S, Fujimoto H, Kanai Y. DNA methyltransferase 3B expression is associated with poor outcome of stage I testicular seminoma. Histopathology. 2012;60(6B):E12–8. doi:10.1111/j.1365-2559.2012.04174.x (Epub 6 March 2012).